Volume 15 Supplement 1
Proceedings of the International Cancer Imaging Society (ICIS) 15th Annual Teaching Course
Meeting abstracts
Publication charges for this supplement were funded through the International Cancer Imaging Society by support received from Siemens Healthcare GmbH.
International Cancer Imaging Society Meeting and 15th Annual Teaching Course (ICIS 2015). Go to conference site.
London, UK5-7 October 2015
Page 1 of 3
-
Citation: Cancer Imaging 2015 15(Suppl 1):O1
-
Establishing proforma reporting in a busy DGH
Citation: Cancer Imaging 2015 15(Suppl 1):O2 -
US perspective
Citation: Cancer Imaging 2015 15(Suppl 1):O3 -
Spots and dots in the bones
Citation: Cancer Imaging 2015 15(Suppl 1):O4 -
Imaging of the pancreas: state of the art
Citation: Cancer Imaging 2015 15(Suppl 1):O5 -
Imaging of IPMN of the pancreas: evaluation of malignant potential and resectability
Citation: Cancer Imaging 2015 15(Suppl 1):O6 -
Using structured reporting templates in staging pancreatic malignancies
Citation: Cancer Imaging 2015 15(Suppl 1):O7 -
Augmented reality: 3D image-guided surgery
Citation: Cancer Imaging 2015 15(Suppl 1):O8 -
Translating imaging biomarkers into clinical practice
Citation: Cancer Imaging 2015 15(Suppl 1):O9 -
Small bowel masses
Citation: Cancer Imaging 2015 15(Suppl 1):O10 -
Management of splenic “incidentalomas” found on ultrasound and computed tomography
Citation: Cancer Imaging 2015 15(Suppl 1):O11 -
Small renal masses
Citation: Cancer Imaging 2015 15(Suppl 1):O12 -
Lung cancer screening: 360 degree review
Citation: Cancer Imaging 2015 15(Suppl 1):O13 -
Imaging tumour response - challenges
Citation: Cancer Imaging 2015 15(Suppl 1):O14 -
PET/CT imaging in prostate cancer
Citation: Cancer Imaging 2015 15(Suppl 1):O15 -
Theranostics: radionuclide imaging and therapy in neuroendocrine tumours
Citation: Cancer Imaging 2015 15(Suppl 1):O16 -
Microbubbles: from cancer detection to theranostics
Citation: Cancer Imaging 2015 15(Suppl 1):O17 -
MRI with hepatobiliary contrast
Citation: Cancer Imaging 2015 15(Suppl 1):O18 -
Ultrasound with microbubbles
Citation: Cancer Imaging 2015 15(Suppl 1):O19 -
Lung cancer staging
Citation: Cancer Imaging 2015 15(Suppl 1):O20 -
Imaging the Ancients
Citation: Cancer Imaging 2015 15(Suppl 1):O21 -
Benign lesions that mimic cancer: Ovarian
Citation: Cancer Imaging 2015 15(Suppl 1):O22 -
Lung and pleura
Citation: Cancer Imaging 2015 15(Suppl 1):O23 -
Liver and pancreas
Citation: Cancer Imaging 2015 15(Suppl 1):O24 -
Salivary glands and lymph nodes
Citation: Cancer Imaging 2015 15(Suppl 1):O25 -
MRI assessment of treatment response
Citation: Cancer Imaging 2015 15(Suppl 1):O26 -
Orbital tumours
Citation: Cancer Imaging 2015 15(Suppl 1):O27 -
Hepatic lesions
Citation: Cancer Imaging 2015 15(Suppl 1):O28 -
Ablation for metastatic lung cancer
Citation: Cancer Imaging 2015 15(Suppl 1):O29 -
Percutaneous treatment of liver metastases
Citation: Cancer Imaging 2015 15(Suppl 1):O30 -
MR guided focused ultrasound
Citation: Cancer Imaging 2015 15(Suppl 1):O31 -
PET/MR imaging: current status and future direction
Citation: Cancer Imaging 2015 15(Suppl 1):O32 -
Imaging and cancer survivorship: challenges and changing concepts
Citation: Cancer Imaging 2015 15(Suppl 1):O33 -
Imaging techniques to diagnose radiation damage
Citation: Cancer Imaging 2015 15(Suppl 1):O34 -
Chemo cured the cancer: what about the patient?
Citation: Cancer Imaging 2015 15(Suppl 1):O35 -
Pediatric bone and soft-tissue sarcomas
Citation: Cancer Imaging 2015 15(Suppl 1):O36 -
Paediatric renal tumors
Citation: Cancer Imaging 2015 15(Suppl 1):O37 -
Ovarian cancer: imaging in treatment selection and planning with FIGO update
Citation: Cancer Imaging 2015 15(Suppl 1):O38 -
Brain gliomas: reporting essentials and treatment response
Citation: Cancer Imaging 2015 15(Suppl 1):O39 -
Brain lesions in oncology patients: recognising metastatic versus non metastatic lesions
Citation: Cancer Imaging 2015 15(Suppl 1):O40 -
Advanced abdominal imaging with dual energy CT is feasible without increasing radiation dose
Citation: Cancer Imaging 2015 15(Suppl 1):P1 -
Contrast enhancement for early cancer imaging by Gd-nanoparticles and active feedback MRI
Citation: Cancer Imaging 2015 15(Suppl 1):P2 -
Increase in lesion enhancement on gadoxetic acid enhanced MRI is associated with complete response to neoadjuvant chemotherapy in colorectal liver metastases
Citation: Cancer Imaging 2015 15(Suppl 1):P3 -
Hepatocellularcarcinoma: current imaging techniques
Citation: Cancer Imaging 2015 15(Suppl 1):P4 -
Role of MRI in evaluation of small bowel disease
Citation: Cancer Imaging 2015 15(Suppl 1):P5 -
Factors in the success of the subcutaneous central venous port catheter in 626 colorectal carcinoma patients: long-term follow-up results according to the treatment groups
Citation: Cancer Imaging 2015 15(Suppl 1):P6 -
Characterisation of hepatobiliary lesions in an African referral hospital: initial MDCT dose challenges
Citation: Cancer Imaging 2015 15(Suppl 1):P7 -
First case report of usefulness of 18F-FDG PET/CT in diagnosing typhlitis (an oncological emergency)
Citation: Cancer Imaging 2015 15(Suppl 1):P8 -
Oxygen-enhanced MRI can accurately identify, quantify and map tumour hypoxia in preclinical models
Citation: Cancer Imaging 2015 15(Suppl 1):P9 -
Role of molecular functional imaging in present era of evidence based cancer medicine: to image or to imagine?
Citation: Cancer Imaging 2015 15(Suppl 1):P10
Currently, all abstracts in this supplement can be viewed using the Concatenated PDF 15S1.
Official journal of
-
Cancer Imaging is the official journal of the International Cancer Imaging Society (ICIS)
Follow
Annual Journal Metrics
-
Citation Impact 2023
Journal Impact Factor: 3.5
5-year Journal Impact Factor: 4.3
Source Normalized Impact per Paper (SNIP): 1.416
SCImago Journal Rank (SJR): 1.227Speed 2024
Submission to first editorial decision (median days): 11
Submission to acceptance (median days): 157Usage 2024
Downloads: 976,377
Altmetric mentions: 193